Clinical Trial Update: Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: The PREVAIL Study [Phase 2]

View source ↗

Summary

The PREVAIL Phase 2 trial evaluating lactoferrin for prevention of nosocomial infections in critically ill patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Nosocomial Infection

Drugs mentioned

• Lactoferrin (lactoferrin)

Snippet

Sponsor: Queen's University | Conditions: Critically Ill | Phase 2 | Status: COMPLETED